Independent
Tenure on this board
14.4 yrs
10 nominees · 5 ballot items.
Election of ten directors; Ratification of Deloitte & Touche LLP as independent auditor; Advisory (non-binding) approval of executive compensation; Amendment to By-laws to allow shareholders owning 25% to call a special meeting; Shareholder proposal requiring certain executives to retain 25% of net after-tax shares acquired through equity pay programs (with proponent John Chevedden).
Elect ten nominees to the board for one-year terms.
Ratify the audit committee’s selection of Deloitte & Touche LLP as Revvity’s independent registered public accounting firm for fiscal 2026.
Advisory vote to approve executive compensation as disclosed in the proxy (Compensation Discussion and Analysis and tables).
Amend By-laws to lower the ownership threshold to call special shareholder meetings from 40% to 25%.
Shareholder-submitted proposal (proponent John Chevedden) requesting a policy requiring the five named executive officers to retain 25% of net after-tax shares acquired through equity pay programs until retirement and prohibiting hedging of those shares.
The shareholder proposal from John Chevedden requests a policy requiring the five named executive officers to retain 25% of net after-tax shares acquired through equity pay programs until retirement and to prohibit hedging of those shares. The proponent argues this would better align executives with long-term shareholder interests in light of stock price decline and operational headwinds, citing specific business challenges and litigation exposure. Management opposes on grounds that existing stock ownership guidelines, clawbacks, hedging prohibitions, and 10b5-1 plans already align interests; that the proposal could hinder recruitment/retention and be administratively burdensome; and that the company’s peer group does not adopt such a retention mandate. The board recommends voting AGAINST.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | 19.9% | 22,198,422 | $1.9B |
| 2 | PRICE T ROWE ASSOCIATES INC /MD/ | 8.9% | 9,921,128 | $869M |
| 3 | EdgePoint Investment Group Inc. | 7.9% | 8,800,863 | $771M |
| 4 | JANUS HENDERSON GROUP PLC | 7.0% | 7,822,280 | $685M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 6.6% | 7,329,980 | $642M |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.3% | 4,813,167 | $422M |
| 7 | STATE STREET CORP | 3.9% | 4,310,313 | $378M |
| 8 | BlackRock, Inc. | 3.0% | 3,355,603 | $294M |
| 9 | VICTORY CAPITAL MANAGEMENT INC | 2.9% | 3,204,127 | $281M |
| 10 | DIMENSIONAL FUND ADVISORS LP | 2.5% | 2,754,075 | $241M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.